These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26415740)

  • 81. Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
    Rönnelid J; Hansson M; Mathsson-Alm L; Cornillet M; Reed E; Jakobsson PJ; Alfredsson L; Holmdahl R; Skriner K; Serre G; Lundberg K; Klareskog L
    Ann Rheum Dis; 2018 Feb; 77(2):203-211. PubMed ID: 29070529
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.
    Yadav R; Yoo DG; Kahlenberg JM; Bridges SL; Oni O; Huang H; Stecenko A; Rada B
    J Cyst Fibros; 2019 Sep; 18(5):636-645. PubMed ID: 30638826
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gene-environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2014 Jun; 17(5):528-35. PubMed ID: 24618101
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.
    Skare TL; Nisihara R; Barbosa BB; da Luz A; Utiyama S; Picceli V
    Clin Rheumatol; 2013 Jul; 32(7):1065-70. PubMed ID: 23412637
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
    Kakumanu P; Sobel ES; Narain S; Li Y; Akaogi J; Yamasaki Y; Segal MS; Hahn PC; Chan EK; Reeves WH; Satoh M
    J Rheumatol; 2009 Dec; 36(12):2682-90. PubMed ID: 19884269
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
    Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L
    Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis--new pathways to epitope spreading.
    Roth EB; Stenberg P; Book C; Sjöberg K
    Clin Exp Rheumatol; 2006; 24(1):12-8. PubMed ID: 16539813
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects.
    Terao C; Ohmura K; Kochi Y; Ikari K; Maruya E; Katayama M; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
    Ann Rheum Dis; 2011 Dec; 70(12):2134-9. PubMed ID: 21873689
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
    Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
    Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Association of HLA-DR4, PAD4, and STAT4 expression in the peripheral blood with disease activity in patients with rheumatoid arthritis].
    Lü Z; Li J; Feng ZT; Ren J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1349-53. PubMed ID: 20584675
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
    Lac P; Racapé M; Barra L; Bell DA; Cairns E
    J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients.
    Kolarz B; Ciesla M; Rosenthal AK; Dryglewska M; Majdan M
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X21989868. PubMed ID: 33628335
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
    Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
    Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
    Damgaard D; Senolt L; Nielsen CH
    Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
    Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
    Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
    Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
    Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
    Sidiras P; Spruyt D; Gangji V; Imbault V; Sokolova T; Durez P; Communi D; Rasschaert J; Badot V
    Scand J Rheumatol; 2021 Mar; 50(2):118-123. PubMed ID: 33025839
    [No Abstract]   [Full Text] [Related]  

  • 100. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
    Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
    Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.